Vascular Health and Risk Management (Oct 2021)
Updating the VIVOPTIM Program for the Assessment of Cardiovascular Risk
Abstract
Jacques Blacher,1 Virginie Femery2 On behalf of the VIVOPTIM medical committee1Diagnosis and Therapeutic Center, Hôtel-Dieu Hospital; Université de Paris; AP-HP, Paris, France; 2Department of Executive Management, VIVOPTIM Solutions, Paris, FranceCorrespondence: Jacques BlacherUniversité de Paris; Assistance Publique-Hôpitaux de Paris; Unité HTA, Prévention et Thérapeutique Cardiovasculaires, Centre de Diagnostic et de Thérapeutique, Hôpital Hôtel-Dieu, Place du Parvis Notre-Dame, Paris 75004, FranceTel +33 1 42 34 89 66Fax +33 1 42 34 86 32Email [email protected]
